Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Karolinska Development Revenue (TTM): 0.1834M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.1834M |
| December 31, 2023 | 0.1906M |
| September 30, 2023 | 0.193M |
| June 30, 2023 | 0.205M |
| March 31, 2023 | 0.2189M |
| December 31, 2022 | 0.2297M |
| September 30, 2022 | 0.2302M |
| June 30, 2022 | 0.2375M |
| March 31, 2022 | 0.2424M |
| December 31, 2021 | 0.2542M |
| September 30, 2021 | 0.2625M |
| June 30, 2021 | 0.2535M |
| March 31, 2021 | 0.246M |
| December 31, 2020 | 0.2857M |
| September 30, 2020 | 0.3001M |
| June 30, 2020 | 0.3259M |
| March 31, 2020 | 0.375M |
| December 31, 2019 | 0.3589M |
| September 30, 2019 | 0.3773M |
| June 30, 2019 | 0.3844M |
| March 31, 2019 | 0.3619M |
| December 31, 2018 | 0.3538M |
| September 30, 2018 | 0.3498M |
| June 30, 2018 | 0.3345M |
| March 31, 2018 | 0.3105M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.289M |
| September 30, 2017 | 0.6091M |
| June 30, 2017 | 0.5941M |
| March 31, 2017 | 0.6044M |
| December 31, 2016 | 0.6074M |
| September 30, 2016 | 0.2567M |
| June 30, 2016 | 0.2438M |
| March 31, 2016 | 0.3027M |
| December 31, 2015 | 0.35M |
| September 30, 2015 | 0.5029M |
| June 30, 2015 | 0.6223M |
| March 31, 2015 | 0.6573M |
| December 31, 2014 | 0.7314M |
| September 30, 2014 | 0.6639M |
| June 30, 2014 | 0.7458M |
| March 31, 2014 | 0.7587M |
| December 31, 2013 | 0.76M |
| September 30, 2013 | 1.002M |
| June 30, 2013 | 1.032M |
| March 31, 2013 | 1.295M |
| December 31, 2012 | 1.467M |
| September 30, 2012 | 1.579M |
| June 30, 2012 | 1.608M |
| March 31, 2012 | 1.529M |
| December 31, 2011 | 1.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1834M
Minimum
Mar 2024
0.3844M
Maximum
Jun 2019
0.2677M
Average
0.2497M
Median
Revenue (TTM) Benchmarks
| Abliva AB | -- |
| Calliditas Therapeutics AB | 123.97M |
| Oncopeptides AB | 2.890M |
| Olink Holding AB | 170.89M |
| BioInvent International AB | 5.746M |